共 50 条
- [1] Glucagon-Like Peptide-1 Receptor Agonists JOURNAL OF FAMILY PRACTICE, 2017, 66 (10): : S12 - S16
- [2] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 788 - 805
- [4] Glucagon-Like Peptide-1 Receptor Agonists and Osteoarthritis NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (17): : 1643 - 1644
- [5] Obesity and Glucagon-Like Peptide-1 Receptor Agonists JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (07): : 561 - 562
- [6] Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (02): : 113 - 114
- [10] Cardiovascular safety of albiglutide and other glucagon-like peptide-1 receptor agonists LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (09): : 667 - 669